Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents

Multiple sclerosis is a heterogenous disease. Although several EMA-approved disease-modifying treatments including biopharmaceuticals are available, their efficacy is limited, and a certain percentage of patients are always nonresponsive. Drug efficacy monitoring is an important tool to identify the...

Descripción completa

Detalles Bibliográficos
Autores principales: Caldano, Marzia, Raoul, William, Rispens, Theo, Bertolotto, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2017
Materias:
Biopharmaceuticals: Focus on Therapeutic Drug Monitoring
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538300/
https://www.ncbi.nlm.nih.gov/pubmed/28328761
http://dx.doi.org/10.1097/FTD.0000000000000393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538300/
https://www.ncbi.nlm.nih.gov/pubmed/28328761
http://dx.doi.org/10.1097/FTD.0000000000000393

Ejemplares similares